Two Sigma Securities’s Catalyst Pharmaceutical CPRX Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2024
Q2 | – | Sell |
-12,107
| Closed | -$193K | – | 1633 |
|
2024
Q1 | $193K | Buy |
+12,107
| New | +$193K | ﹤0.01% | 894 |
|
2021
Q4 | – | Sell |
-25,664
| Closed | -$136K | – | 1088 |
|
2021
Q3 | $136K | Buy |
+25,664
| New | +$136K | ﹤0.01% | 598 |
|
2020
Q4 | – | Sell |
-26,496
| Closed | -$79K | – | 748 |
|
2020
Q3 | $79K | Buy |
+26,496
| New | +$79K | ﹤0.01% | 416 |
|
2019
Q3 | – | Sell |
-10,336
| Closed | -$40K | – | 812 |
|
2019
Q2 | $40K | Sell |
10,336
-14,309
| -58% | -$55.4K | ﹤0.01% | 716 |
|
2019
Q1 | $126K | Buy |
+24,645
| New | +$126K | ﹤0.01% | 600 |
|
2018
Q1 | – | Sell |
-26,658
| Closed | -$104K | – | 1224 |
|
2017
Q4 | $104K | Buy |
26,658
+15,178
| +132% | +$59.2K | ﹤0.01% | 751 |
|
2017
Q3 | $29K | Buy |
+11,480
| New | +$29K | ﹤0.01% | 744 |
|
2017
Q2 | – | Sell |
-12,863
| Closed | -$25K | – | 903 |
|
2017
Q1 | $25K | Buy |
12,863
+1,260
| +11% | +$2.45K | ﹤0.01% | 838 |
|
2016
Q4 | $12K | Buy |
+11,603
| New | +$12K | ﹤0.01% | 668 |
|